LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Combined, the business will incorporate products like GSK's Tums and Excedrin with Pfizer's Advil and vitamins business. For years, the businesses had been a sure and steady income stream for the ...